ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CYTO Altamira Therapeutics Ltd

1.68
0.08 (5.00%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Altamira Therapeutics Financial Summary

The current CYTO market cap is 587.16k. The company's latest EPS is CHF -75.9027 and P/E is -0.04.

Quarter End Mar 2014
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 0
Operating Income -5.86M
Net Income -5.86M
Year End December 30 2022 20182019202020212022
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 00064k306k
Operating Income -11.47M-7.26M-5.5M-17.1M-26.13M
Net Income -11.5M-6.63M-8.2M-17.39M-26.53M
Quarter End Mar 2014
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Assets 20.86M
Total Liabilities 3.99M
Total Equity 16.88M
Year End December 30 2022 20182019202020212022
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Assets 9.88M9.23M20.8M18.84M6.3M
Total Liabilities 6.23M3.19M4.03M6.13M14.62M
Total Equity 3.65M6.04M16.77M12.71M-8.32M
Quarter End Mar 2014
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Operating -5.19M
Investing -57k
Financing -87k
Year End December 30 2022 20182019202020212022
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Operating -13.23M-8.39M-4.84M-13.67M-8.68M
Investing -1.82M-3M-2.32M-3.51M-2.14M
Financing 5.73M7.38M16.96M6.61M9.83M
Market Cap 587.16k
Price to Earnings Ratio -0.04
Price to Sales Ratio 3.47
Price to Cash Ratio 70.86
Price to Book Ratio -0.13
Dividend Yield -

Share Statistics

Shares Outstanding 349.5k
Average Volume (1 week) 714.36k
Average Volume (1 Month) 269.15k
52 Week Change -91.26%
52 Week High 28.40
52 Week Low 1.35
Spread (Intraday) 0.07 (4.07%)

Company Info

Company Name Altamira Therapeutics Ltd
Address dornacherstrasse 210
basel 4053
Website https://altamiratherapeutics.com
Industry med, dental, hosp eq-whsl (5047)

Your Recent History

Delayed Upgrade Clock